Wells Fargo’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Wells Fargo’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25	Closed	–	–	7787
2020 Q4	$0	Hold	25	–	–	﹤0.01%	7449
2020 Q3	$0	Sell	25 -1	-4%	-$5	﹤0.01%	7342
2020 Q2	$0	Hold	26	–	–	﹤0.01%	7256
2020 Q1	$0	Buy	+26	New	+$188	﹤0.01%	7284
2017 Q3	–	Sell	-14	Closed	–	–	6575
2017 Q2	$0	Hold	14	–	–	﹤0.01%	6586
2017 Q1	$0	Hold	14	–	–	﹤0.01%	6634
2016 Q4	$1K	Hold	14	–	–	﹤0.01%	6203
2016 Q3	$0	Hold	14	–	–	﹤0.01%	6448
2016 Q2	$0	Hold	14	–	–	﹤0.01%	6472
2016 Q1	$0	Hold	14	–	–	﹤0.01%	6561
2015 Q4	$1K	Hold	14	–	–	﹤0.01%	6142
2015 Q3	$3K	Buy	14 +4	+40%	+$788	﹤0.01%	5953
2015 Q2	$1K	Buy	+10	New	+$1.39K	﹤0.01%	6279

Other funds holding IDXG

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo's IDXG Position: Q1 2021 in Review

Wells Fargo sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2021, closing a stake of 25 shares.

Wells Fargo first reported a position in IDXG in Q2 2015 and held it in 13 quarters. The position peaked at $3K in Q3 2015. 3 funds tracked by Wall St. Rank hold IDXG as of Q1 2021.

Wells Fargo reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Wells Fargo sold 25 Interpace Biosciences, Inc. Common Stock shares in Q1 2021.
Wells Fargo first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2015 and held it in 13 quarters.
Wells Fargo's Interpace Biosciences, Inc. Common Stock position peaked at $3K in Q3 2015.
3 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.